PAVmed Provides Business Update and Third Quarter 2024 Financial[...]
Candel Therapeutics Reports Third Quarter 2024 Financial Results and[...]
Moleculin Accelerates Planned Unblinded Data Readout for MIRACLE Phase[...]
11/13/2024 | Press release | Distributed by Public on 11/13/2024 14:47
Please select the service you want to use:
Smartlinks | The eRulemaking Program | News | Environment | Pollution | Air Pollution | Politics and Policy | Government | National Government | Government Agencies
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact